Accéder au contenu
Merck

c-Abl kinase regulates neutrophil extracellular trap formation and lung injury in abdominal sepsis.

Laboratory investigation; a journal of technical methods and pathology (2021-11-05)
Avin Hawez, Zhiyi Ding, Dler Taha, Raed Madhi, Milladur Rahman, Henrik Thorlacius
RÉSUMÉ

Sepsis is associated with exaggerated neutrophil responses although mechanisms remain elusive. The aim of this study was to investigate the role of c-Abelson (c-Abl) kinase in neutrophil extracellular trap (NET) formation and inflammation in septic lung injury. Abdominal sepsis was induced by cecal ligation and puncture (CLP). NETs were detected by electron microscopy in the lung and by confocal microscopy in vitro. Plasma levels of DNA-histone complexes, interleukin-6 (IL-6) and CXC chemokines were quantified. CLP-induced enhanced phosphorylation of c-Abl kinase in circulating neutrophils. Administration of the c-Abl kinase inhibitor GZD824 not only abolished activation of c-Abl kinase in neutrophils but also reduced NET formation in the lung and plasma levels of DNA-histone complexes in CLP mice. Moreover, inhibition of c-Abl kinase decreased CLP-induced lung edema and injury. Administration of GDZ824 reduced CLP-induced increases in the number of alveolar neutrophils. Inhibition of c-Abl kinase also markedly attenuated levels of CXC chemokines in the lung and plasma as well as IL-6 levels in the plasma of septic animals. Taken together, this study demonstrates that c-Abl kinase is a potent regulator of NET formation and we conclude that c-Abl kinase might be a useful target to ameliorate lung damage in abdominal sepsis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4G10® Platinum, Anti-Phosphotyrosine Antibody, Biotin Conjugate, clone 4G10®, Upstate®, from mouse